These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18603830)

  • 1. The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression.
    Suzuki T; Tamehiro N; Sato Y; Kobayashi T; Ishii-Watabe A; Shinozaki Y; Nishimaki-Mogami T; Hashimoto T; Asakawa Y; Inoue K; Ohno Y; Yamaguchi T; Kawanishi T
    J Pharmacol Sci; 2008 Jul; 107(3):285-94. PubMed ID: 18603830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation.
    Fujino T; Une M; Imanaka T; Inoue K; Nishimaki-Mogami T
    J Lipid Res; 2004 Jan; 45(1):132-8. PubMed ID: 13130122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5beta-Cholane activators of the farnesol X receptor.
    Fukuchi J; Song C; Dai Q; Hiipakka RA; Liao S
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):311-8. PubMed ID: 15857750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.
    Pellicciari R; Costantino G; Camaioni E; Sadeghpour BM; Entrena A; Willson TM; Fiorucci S; Clerici C; Gioiello A
    J Med Chem; 2004 Aug; 47(18):4559-69. PubMed ID: 15317466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DRIP205 as a coactivator for the Farnesoid X receptor.
    Pineda Torra I; Freedman LP; Garabedian MJ
    J Biol Chem; 2004 Aug; 279(35):36184-91. PubMed ID: 15187081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
    Wang H; Chen J; Hollister K; Sowers LC; Forman BM
    Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activation of the farnesoid X receptor in the vasculature.
    Bishop-Bailey D; Walsh DT; Warner TD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3668-73. PubMed ID: 14990788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries.
    Nicolaou KC; Evans RM; Roecker AJ; Hughes R; Downes M; Pfefferkorn JA
    Org Biomol Chem; 2003 Mar; 1(6):908-20. PubMed ID: 12929628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
    Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5Alpha-bile alcohols function as farnesoid X receptor antagonists.
    Nishimaki-Mogami T; Kawahara Y; Tamehiro N; Yoshida T; Inoue K; Ohno Y; Nagao T; Une M
    Biochem Biophys Res Commun; 2006 Jan; 339(1):386-91. PubMed ID: 16300737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue.
    Houten SM; Volle DH; Cummins CL; Mangelsdorf DJ; Auwerx J
    Mol Endocrinol; 2007 Jun; 21(6):1312-23. PubMed ID: 17426284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.